MetLife Investment Management’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-300
Closed -$14.6K 2567
2021
Q3
$14.6K Sell
300
-1,654
-85% -$102K ﹤0.01% 2564
2021
Q2
$165K Buy
1,954
+798
+69% +$68.6K ﹤0.01% 2271
2021
Q1
$117K Sell
1,156
-1,208
-51% -$133K ﹤0.01% 2237
2020
Q4
$238K Sell
2,364
-292
-11% -$19.5K ﹤0.01% 1885
2020
Q3
$123K Buy
2,656
+1,046
+65% +$53.7K ﹤0.01% 2114
2020
Q2
$92.7K Buy
+1,610
New +$107K ﹤0.01% 2274

Other funds holding AWH

MetLife Investment Management's AWH Position: Q4 2021 in Review

MetLife Investment Management sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2021, closing a stake of 300 shares — an estimated $14.6K sold.

MetLife Investment Management first reported a position in AWH in Q2 2020 and held it in 6 quarters. The position peaked at $238K in Q4 2020. 98 funds tracked by Wall St. Rank hold AWH as of Q4 2021.

  • MetLife Investment Management reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 300 Aspira Women's Health Inc. Common Stock shares in Q4 2021, an estimated $14.6K.
  • MetLife Investment Management first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • MetLife Investment Management's Aspira Women's Health Inc. Common Stock position peaked at $238K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.